Alternatively, a study on pancreatic cancer demonstrated that gemcitabine, a common chemotherapeutic drug, induced cytotoxicity through ROS generated by NADPH oxidase (NOX) and through the increase of p22 (phox) expression via NF-κB activation. Here, FMO5 is linked to familial pancreatic carcinoma.